-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Fusion Pharmaceuticals Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2019 to 2023.
- Fusion Pharmaceuticals Inc. Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was -$237K, a 2055% decline year-over-year.
- Fusion Pharmaceuticals Inc. Income Tax Expense (Benefit) for the twelve months ending March 31, 2024 was $561K.
- Fusion Pharmaceuticals Inc. annual Income Tax Expense (Benefit) for 2023 was $787K.
- Fusion Pharmaceuticals Inc. annual Income Tax Expense (Benefit) for 2022 was -$1.84M, a 1457% decline from 2021.
- Fusion Pharmaceuticals Inc. annual Income Tax Expense (Benefit) for 2021 was -$118K, a 105% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)